% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • froy99_99 froy99_99 Feb 8, 2012 11:11 AM Flag

    Curious choice of words re Lovenox:

    SNY’s Chris Viehbacher said on today’s CC that SNY *expects* a new competitor (Amphastar/WPI) to launch; however, Viehbacher did not say that Amphastar/WPI had in fact launched, and one would presume that SNY would know about such a launch very quickly.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Viehbacher’s comment meant nothing, evidently, and we now have the worst-case scenario. The Lovenox patent-infringement lawsuit still holds some value for MNTA, but the lawsuit’s NPV for MNTA is greatly reduced with a settlement presumably off the table.

      Support for the shape price will now have to come from the fact that the enterprise value (market cap less cash on hand) is very low, even if one values the NPV of the Lovenox royalty stream very conservatively.

    • If we assume that a settlement will occur, which seems to become more likely with each passing day, what would be your guess about deal terms and stock reaction?

11.87-0.22(-1.82%)Sep 23 4:00 PMEDT